Publications by authors named "Jean Claude Barbare"

Claim this Profile
R
Real-life data on hepatocellular carcinoma in the French prospective CHIEF cohort in the era of immunotherapy.
Eric Nguyen-Khac, Philippe Merle, Hajer Ben Khadhra, Amaddeo Giuliana, Thomas Decaens, Jean Claude Barbare

Eur J Gastroenterol Hepatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatocellular carcinoma: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, AFEF, SIAD, SFR/FRI).
Jean Frédéric Blanc, Audrey Debaillon-Vesque, Gaël Roth, Jean Claude Barbare, Anne Sophie Baumann

Clin Res Hepatol Gastroenterol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geographical Disparities of Outcomes of Hepatocellular Carcinoma in France: The Heavier Burden of Alcohol Compared to Hepatitis C.
Charlotte E Costentin, Philippe Sogni, Bruno Falissard, Jean-Claude Barbare, Noelle Bendersky

Dig Dis Sci· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idarubicin-loaded Beads for Chemoembolization of Hepatocellular Carcinoma: The IDASPHERE II Single-Arm Phase II Trial.
Boris Guiu, Patrick Chevallier, Eric Assenat, Emilie Barbier, Philippe Merle, Jean-Claude Barbare

Radiology· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early decrease in serum amphiregulin or vascular endothelial growth factor levels predicts sorafenib efficacy in hepatocellular carcinoma.
Corinne Godin, Sandra Bodeau, Zuzana Saidak, Christophe Louandre, Catherine François, Jean-Claude Barbare

Oncol Rep· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Care pathway of patients with hepatocellular carcinoma in France: State of play in 2017].
Charlotte Costentin, Nathalie Ganne-Carrié, Benoit Rousseau, René Gérolami, Jean-Claude Barbare

Bull Cancer· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geographical variations in incidence, management and survival of hepatocellular carcinoma in a Western country.
Nathalie Goutté, Philippe Sogni, Noelle Bendersky, Jean Claude Barbare, Bruno Falissard

J Hepatol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpha-foetoprotein (AFP): A multi-purpose marker in hepatocellular carcinoma.
Chloé Sauzay, Alexandra Petit, Anne-Marie Bourgeois, Jean-Claude Barbare, Bruno Chauffert

Clin Chim Acta· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib.
Aline Houessinon, Catherine François, Chloé Sauzay, Christophe Louandre, Gaelle Mongelard, Jean-Claude Barbare

Mol Cancer· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpha-fetoprotein is a biomarker of unfolded protein response and altered proteostasis in hepatocellular carcinoma cells exposed to sorafenib.
Aline Houessinon, Albane Gicquel, Flora Bochereau, Christophe Louandre, Rémy Nyga, Jean-Claude Barbare

Cancer Lett· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The endless SEARCH for a better medical treatment of advanced hepatocellular carcinoma.
Antoine Galmiche, Momar Diouf, Jean-Claude Barbare

Clin Res Hepatol Gastroenterol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers of apoptosis and necrosis in patients with hepatocellular carcinoma treated with sorafenib.
Corinne Godin, Christophe Louandre, Sandra Bodeau, Momar Diouf, Zuzana Saidak, Jean-Claude Barbare

Anticancer Res· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells.
Christophe Louandre, Ingrid Marcq, Hicham Bouhlal, Emma Lachaier, Corinne Godin, Jean-Claude Barbare

Cancer Lett· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal cut points for quality of life questionnaire-core 30 (QLQ-C30) scales: utility for clinical trials and updates of prognostic systems in advanced hepatocellular carcinoma.
Momar Diouf, Franck Bonnetain, Jean-Claude Barbare, Olivier Bouché, Laetitia Dahan

Oncologist· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Should cases of hepatocellular carcinoma be discussed by non-specialized multidisciplinary team meetings?].
Jean-Claude Barbare, Dominique Franco, Thierry André, Jean-Pierre Bronowicki, Philippe Merle

Bull Cancer· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New biological perspectives for the improvement of the efficacy of sorafenib in hepatocellular carcinoma.
Antoine Galmiche, Bruno Chauffert, Jean-Claude Barbare

Cancer Lett· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib.
Christophe Louandre, Zakaria Ezzoukhry, Corinne Godin, Jean-Claude Barbare, Jean-Claude Mazière

Int J Cancer· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneous sensitivity of hepatocellular carcinoma to sorafenib revealed by the short-term culture of tumor fragments.
Corinne Godin, Sebastien Dupont, Zakaria Ezzoukhry, Christophe Louandre, Denis Chatelain, Jean-Claude Barbare

Anticancer Res· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The added value of quality of life (QoL) for prognosis of overall survival in patients with palliative hepatocellular carcinoma.
Momar Diouf, Thomas Filleron, Jean-Claude Barbare, Loïc Fin, Carl Picard

J Hepatol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Why no consensus prognostic classification for hepatocellular carcinoma?].
Jean-Claude Barbare, Amandine Bellenguez, Momar Diouf

Rev Prat· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EGFR activation is a potential determinant of primary resistance of hepatocellular carcinoma cells to sorafenib.
Zakaria Ezzoukhry, Christophe Louandre, Eric Trécherel, Corinne Godin, Bruno Chauffert, Jean-Claude Barbare

Int J Cancer· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a new prognostic score of death for patients with hepatocellular carcinoma in palliative setting.
Caroline Tournoux-Facon, Xavier Paoletti, Jean-Claude Barbare, Olivier Bouché, Philippe Rougier

J Hepatol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BAD, a proapoptotic member of the BCL2 family, is a potential therapeutic target in hepatocellular carcinoma.
Antoine Galmiche, Zakaria Ezzoukhry, Catherine François, Christophe Louandre, Charles Sabbagh, Jean-Claude Barbare

Mol Cancer Res· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Marked iron overload related to ribavirin and iron sulfate treatment in a patient with active viral C cirrhosis.
Vincent Jouannaud, Jean-François Cadranel, Patrice Dumouchel, Alain Cazier, Dominique Capron, Jean-Claude Barbare

Eur J Gastroenterol Hepatol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Somatostatin receptor scintigraphy screening in advanced hepatocarcinoma: A multi-center French study.
Eric Nguyen-Khac, Isabelle Ollivier, Thomas Aparicio, Véronique Moullart, Alexis Hugentobler, Jean Claude Barbare

Cancer Biol Ther· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis